Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)

SHA:688336 Revenue

Sunshine Guojian Pharmaceutical (Shanghai) had revenue of 330.89M CNY in the quarter ending June 30, 2025, with 0.35% growth. This brings the company's revenue in the last twelve months to 1.24B, up 9.37% year-over-year. In the year 2024, Sunshine Guojian Pharmaceutical (Shanghai) had annual revenue of 1.19B with 17.70% growth.

• Revenue (ttm): 1.24B
• Revenue Growth: +9.37%
• P/S Ratio: 27.70
• Revenue / Employee: 1.21M
• Employees: 995
• Market Cap: 34.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.19B	179.53M	17.70%
Dec 31, 2023	1.01B	188.54M	22.84%
Dec 31, 2022	825.49M	-103.32M	-11.12%
Dec 31, 2021	928.81M	273.80M	41.80%
Dec 31, 2020	655.01M	-522.39M	-44.37%